Nonetheless, pending prospective validation, our results suggest that compared with TKI treatment alone, RT does significantly improve both PFS and OS in medically inoperable EGFR-mutant adenocarcinoma of the lung compared with TKI alone. This evidence concerns the gene EGFR and lung adenocarcinoma.